Skip to content

WUILOSXIDSOOFW-GVYLPFDPSA-N

C35H40ClF4N9O3 — CID 139305731

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPAC[(2S)-2-[(4R)-2-amino-4-[4-[1-(difluoromethyl)pyrazol-4-yl]-1-methylcyclohexa-2,4-dien-1-yl]-4-(2,2-dimethylpropyl)-5-oxoimidazol-1-yl]-2-[4-chloro-3-(1H-1,2,4-triazol-5-yl)phenyl]ethyl] N-cyclopropyl-N-(2,2-difluoroethyl)carbamate
SMILESCC(C)(C)C[C@]1(C2(C)C=CC(c3cnn(C(F)F)c3)=CC2)N=C(N)N([C@H](COC(=O)N(CC(F)F)C2CC2)c2ccc(Cl)c(-c3ncn[nH]3)c2)C1=O
InChIInChI=1S/C35H40ClF4N9O3/c1-33(2,3)18-35(34(4)11-9-20(10-12-34)22-14-44-48(15-22)30(39)40)29(50)49(31(41)45-35)26(17-52-32(51)47(16-27(37)38)23-6-7-23)21-5-8-25(36)24(13-21)28-42-19-43-46-28/h5,8-11,13-15,19,23,26-27,30H,6-7,12,16-18H2,1-4H3,(H2,41,45)(H,42,43,46)/t26-,34?,35+/m1/s1
InChIKeyWUILOSXIDSOOFW-GVYLPFDPSA-N
MW746.21 g/mol
LogP7.01
Rot. Bonds12

About WUILOSXIDSOOFW-GVYLPFDPSA-N

WUILOSXIDSOOFW-GVYLPFDPSA-N (PubChem CID 139305731) has the molecular formula C35H40ClF4N9O3 and a molecular weight of 746.21 g/mol. Its IUPAC name is [(2S)-2-[(4R)-2-amino-4-[4-[1-(difluoromethyl)pyrazol-4-yl]-1-methylcyclohexa-2,4-dien-1-yl]-4-(2,2-dimethylpropyl)-5-oxoimidazol-1-yl]-2-[4-chloro-3-(1H-1,2,4-triazol-5-yl)phenyl]ethyl] N-cyclopropyl-N-(2,2-difluoroethyl)carbamate.

Molecular Properties

Compound NameWUILOSXIDSOOFW-GVYLPFDPSA-N
PubChem CID139305731
Molecular FormulaC35H40ClF4N9O3
Molecular Weight746.21 g/mol
Exact Mass745.29
IUPAC Name[(2S)-2-[(4R)-2-amino-4-[4-[1-(difluoromethyl)pyrazol-4-yl]-1-methylcyclohexa-2,4-dien-1-yl]-4-(2,2-dimethylpropyl)-5-oxoimidazol-1-yl]-2-[4-chloro-3-(1H-1,2,4-triazol-5-yl)phenyl]ethyl] N-cyclopropyl-N-(2,2-difluoroethyl)carbamate
SMILESCC(C)(C)C[C@]1(C2(C)C=CC(c3cnn(C(F)F)c3)=CC2)N=C(N)N([C@H](COC(=O)N(CC(F)F)C2CC2)c2ccc(Cl)c(-c3ncn[nH]3)c2)C1=O
InChIInChI=1S/C35H40ClF4N9O3/c1-33(2,3)18-35(34(4)11-9-20(10-12-34)22-14-44-48(15-22)30(39)40)29(50)49(31(41)45-35)26(17-52-32(51)47(16-27(37)38)23-6-7-23)21-5-8-25(36)24(13-21)28-42-19-43-46-28/h5,8-11,13-15,19,23,26-27,30H,6-7,12,16-18H2,1-4H3,(H2,41,45)(H,42,43,46)/t26-,34?,35+/m1/s1
InChIKeyWUILOSXIDSOOFW-GVYLPFDPSA-N
XLogP7.01
TPSA147.62 Ų
H-Bond Donors2
H-Bond Acceptors9
Rotatable Bonds12
Heavy Atoms52
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500746.21
LogP ≤ 57.01
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 109

Analyze WUILOSXIDSOOFW-GVYLPFDPSA-N with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of WUILOSXIDSOOFW-GVYLPFDPSA-N?
The IUPAC name of WUILOSXIDSOOFW-GVYLPFDPSA-N (CID 139305731) is [(2S)-2-[(4R)-2-amino-4-[4-[1-(difluoromethyl)pyrazol-4-yl]-1-methylcyclohexa-2,4-dien-1-yl]-4-(2,2-dimethylpropyl)-5-oxoimidazol-1-yl]-2-[4-chloro-3-(1H-1,2,4-triazol-5-yl)phenyl]ethyl] N-cyclopropyl-N-(2,2-difluoroethyl)carbamate.
What is the SMILES notation for WUILOSXIDSOOFW-GVYLPFDPSA-N?
The canonical SMILES for WUILOSXIDSOOFW-GVYLPFDPSA-N is CC(C)(C)C[C@]1(C2(C)C=CC(c3cnn(C(F)F)c3)=CC2)N=C(N)N([C@H](COC(=O)N(CC(F)F)C2CC2)c2ccc(Cl)c(-c3ncn[nH]3)c2)C1=O.
What is the InChIKey of WUILOSXIDSOOFW-GVYLPFDPSA-N?
The InChIKey is WUILOSXIDSOOFW-GVYLPFDPSA-N. The full InChI is InChI=1S/C35H40ClF4N9O3/c1-33(2,3)18-35(34(4)11-9-20(10-12-34)22-14-44-48(15-22)30(39)40)29(50)49(31(41)45-35)26(17-52-32(51)47(16-27(37)38)23-6-7-23)21-5-8-25(36)24(13-21)28-42-19-43-46-28/h5,8-11,13-15,19,23,26-27,30H,6-7,12,16-18H2,1-4H3,(H2,41,45)(H,42,43,46)/t26-,34?,35+/m1/s1.
What are the key properties of WUILOSXIDSOOFW-GVYLPFDPSA-N?
WUILOSXIDSOOFW-GVYLPFDPSA-N has a molecular weight of 746.21 g/mol, XLogP of 7.01, 12 rotatable bonds, 2 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for WUILOSXIDSOOFW-GVYLPFDPSA-N is sourced from PubChem (CID 139305731), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.